At a glance
- Originator Pfizer
- Class Antihypertensives; Dipeptides; Morpholines
- Mechanism of Action Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 31 Dec 2001 Discontinued for Hypertension in USA (unspecified route)
- 23 Feb 2001 Profile reviewed but no significant changes made
- 09 Jun 1997 No-Development-Reported for Hypertension in USA (Unknown route)